new
   What Are the Indications for Xofluza (Baloxavir Marboxil)?
503
Nov 17, 2025

Xofluza (Baloxavir Marboxil) is a novel anti-influenza virus drug. With its unique single-dose administration regimen and targeted mechanism of action, it provides an innovative option for influenza prevention and control.

What Are the Indications for Xofluza (Baloxavir Marboxil)?

Primary Indications

Therapeutically, it is indicated for infectious diseases caused by influenza A or B viruses.

Indications vary across different drug specifications.

The 20mg tablets and 2% granules are not only used for influenza treatment but also for post-exposure prophylaxis.

The 10mg tablets are only approved for therapeutic purposes and do not have preventive effects.

This drug is ineffective against bacterial infections. If a patient has concurrent bacterial infection or confused symptoms, additional antibacterial treatment is required.

Specifications and Properties of Xofluza (Baloxavir Marboxil)

10mg Tablets

White to pale yellowish-white round uncoated tablets, approximately 5.0mm in diameter, 2.65mm in thickness, and about 61mg in weight.

The tablet surface is engraved with the identification code "771:10" and features a score line for easy dosage adjustment.

20mg Tablets

White to pale yellowish-white oval film-coated tablets, approximately 8.5mm in major diameter, 4.4mm in minor diameter, and about 127mg in weight, with the identification code "772:20".

2% Granules

White to pale yellowish-white granules, with each package containing 500mg.

Storage Requirements for Xofluza (Baloxavir Marboxil)

Unified Storage Conditions

All dosage forms should be sealed and stored at room temperature, avoiding moisture, high temperature, and direct sunlight.

Differences in Expiry Dates

Tablets (10mg/20mg) have an expiry date of 8 years.

Granules have an expiry date of 3 years.

Precautions

Special attention should be paid when delivering the drug: the PTP-packaged tablets must be removed from the aluminum foil blister before administration to prevent serious complications such as esophageal mucosal damage caused by accidental ingestion of the packaging.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
RELATED ARTICLES
Dosage and Administration, Recommended Dose of Elacestrant (Orserdu)

Elacestrant (Orserdu) is a selective estrogen receptor degrader (SERD), which provides an important treatment option...

Friday, December 19th, 2025, 11:49
What Are the Indications for Elacestrant (Orserdu)?

Elacestrant (Orserdu) is a novel endocrine therapy agent that demonstrates significant value in the treatment of...

Friday, December 19th, 2025, 11:40
What Are the Purchase Channels for Elacestrant (Orserdu)?

With the advancement of medical technology, elacestrant (Orserdu), a targeted drug for breast cancer with specific...

Friday, December 19th, 2025, 11:38
Adverse Reactions of Capmatinib (Tabrecta)

Capmatinib (Tabrecta) is a highly selective MET inhibitor indicated for the treatment of patients with advanced...

Friday, December 19th, 2025, 11:35
RELATED MEDICATIONS
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved